Publications by authors named "Michael Glode"

Claim this Profile
G
Guidelines for Sexual Health Care for Prostate Cancer Patients: Recommendations of an International Panel.
Daniela Wittmann, Akanksha Mehta, Eilis McCaughan, Martha Faraday, Ashley Duby

J Sex Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results.
Daniela Wittmann, Akanksha Mehta, Sharon L Bober, Ziwei Zhu, Stephanie Daignault-Newton

Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconsidering the Trade-offs of Prostate Cancer Screening.
Daniela Wittmann, Ted Skolarus, L Michael Glodé

N Engl J Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A familial germline mutation in KIT associated with achalasia, mastocytosis and gastrointestinal stromal tumors shows response to kinase inhibitors.
Alison L Halpern, Robert J Torphy, Martin D McCarter, Cosimo G Sciotto, L Michael Glode

Cancer Genet· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer.
Elizabeth R Kessler, Lih-Jen Su, Dexiang Gao, Kathleen C Torkko, Michael Wacker, L Michael Glode

Integr Cancer Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.
Maha Hussain, Catherine M Tangen, Ian M Thompson, Gregory P Swanson, David P Wood, L Michael Glode

J Clin Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Man With Locally Advanced, High-Risk Prostate Cancer Asks About Adding Chemotherapy to His Treatment.
María T Bourlon, Mauricio Mora, Juan Hinojosa-Fano, Braulio Martínez-Benitez, Arya Amini

Oncology (Williston Park)· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts.
Isabel R Schlaepfer, L Michael Glodé, Carolyn A Hitz, Colton T Pac, Kristen E Boyle

Mol Imaging Biol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in Prostate Cancer (at Last!).
L Michael Glodé

Oncology (Williston Park)· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Base of the skull metastases in metastatic castration-resistant prostate cancer.
Maria T Bourlon, L Michael Glodé, E David Crawford

Oncology (Williston Park)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.
Isabel R Schlaepfer, Leah Rider, Lindsey Ulkus Rodrigues, Miguel A Gijón, Colton T Pac

Mol Cancer Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant and adjuvant hormonal and chemotherapy for prostate cancer.
Elaine T Lam, L Michael Glodé

Hematol Oncol Clin North Am· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancer.
Tomasz M Beer, Paul F Schellhammer, John M Corman, L Michael Glodé, Simon J Hall

Urology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonseminomatous germ cell tumor of testis and interrupted treatment.
L Michael Glodé, Elaine Lam

Oncology (Williston Park)· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer.
Tanya B Dorff, L Michael Glode

Curr Opin Urol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose diethylstilbestrol for the treatment of advanced prostate cancer.
Julia Clemons, L Michael Glodé, Dexiang Gao, Thomas W Flaig

Urol Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer.
Xiaoping Yang, Elizabeth Kessler, Lih-Jen Su, Andrew Thorburn, Arthur E Frankel

Clin Cancer Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in twitter use by physicians at the american society of clinical oncology annual meeting, 2010 and 2011.
Aafia Chaudhry, L Michael Glodé, Matt Gillman, Robert S Miller

J Oncol Pract· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proliferative tumor doubling times of prostatic carcinoma.
Priya N Werahera, L Michael Glode, Francisco G La Rosa, M Scott Lucia, E David Crawford

Prostate Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Pomalidomide in Patients with Castration-Resistant Prostate Cancer.
Robert J Amato, L Michael Glode, Jeremy Podolnick, Robert Knight, David Crawford

Cancers (Basel)· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case of metastatic renal epithelioid angiomyolipoma.
Elaine T Lam, Francisco G La Rosa, Thomas D Suby-Long, Kimi L Kondo, Shandra Wilson

Oncology (Williston Park)· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancer.
Tomasz M Beer, Guy T Bernstein, John M Corman, L Michael Glode, Simon J Hall

Clin Cancer Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study.
Tanya B Dorff, Thomas W Flaig, Catherine M Tangen, Maha H A Hussain, Gregory P Swanson, L Michael Glode

J Clin Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Michelle A Stinauer, Brian D Kavanagh, Tracey E Schefter, Rene Gonzalez, Thomas Flaig, Michael Glode

Radiat Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
Thomas W Flaig, Michael Glodé, Daniel Gustafson, Adrie van Bokhoven, Yuzhen Tao

Prostate· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis